The BARD® VENOVO™ Stent Study – A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease – an Assessment for Effectiveness and Safety (VERNACULAR)


This study is being conducted in partnership with the Midwest Cardiovascular Research Foundation.

The purpose of this study is to evaluate the safety and effectiveness of the VENOVO ™ Venous Stent.

Participants are eligible for this study if they have a blockage in their common and/or external iliac and/or common femoral veins (veins in the abdomen and pelvis) that will be treated with a stent.

Principal Investigator(s)
Nicholas Shammas

Clinical Trial Categories

  • Cardiac Research
Bard Peripheral Vascular, Inc.
Midwest Cardiovascular Research Foundation at 563-324-2828


  • Genesis Medical Center, East Rusholme Street
    1227 East Rusholme Street
    Davenport, IA 52803
    Main: 563-421-1000

Contact Us

For more information about our research program and IRB, please contact:

Research Support Office